Chemotherapy Drugs Current Events | Chemotherapy Drugs News | 8
|
| Page
8 of
55 |
1084 Results |
|
|
|
Sort By:
Page Views | Date |
Study suggests chemotherapy diminishes fertility in breast cancer patients
Pre-menopausal breast cancer survivors who were treated with chemotherapy following surgery were more likely to have diminished ovarian reserve - the capacity of the ovaries to provide eggs capable of being fertilized - compared to women who have never had breast cancer, according to a study led by Dana-Farber Cancer Institute investigators. view more (2008-05-30)
Using PET/CT imaging, UCLA researchers can tell after a single treatment if chemotherapy is working
Oncologists often have to wait months before they can determine whether a treatment is working. Now, using a non-invasive method, researchers at UCLA's Jonsson Comprehensive Cancer Center have shown that they can determine after a single cycle of chemotherapy whether the toxic drugs are killing the cancer or not. view more (2009-04-15)
Experimental Drug Boosts Survival in Recurrent Ovarian Cancer Patients
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently. view more (2007-09-28)
High-dose radiation improves lung cancer survival, U-M study finds
Higher doses of radiation combined with chemotherapy improve survival in patients with stage III lung cancer, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center. view more (2009-04-09)
Surgery remans an option for advanced lung cancer
In recent years, oncologists have debated whether patients with a certain type of advanced lung cancer would benefit from surgery. view more (2009-07-27)
Minimally Invasive Lung Cancer Surgery Can Improve Chemotherapy Outcomes
Patients who undergo a minimally invasive lung cancer surgery called thoracoscopic lobectomy may derive more benefit from the chemotherapy that follows, according to Duke University Medical Center researchers. view more (2007-04-10)
Newer chemotherapies improve outcomes for some types of breast cancer
An updated analysis of findings from three major consecutive clinical trials of breast cancer treatment conducted over the past twenty years indicates that women who have breast cancer with lymph node involvement and estrogen-receptor negative tumors have a lower rate of recurrence and risk of death with treatment with newer chemotherapies. view more (2006-04-12)
Targeted heat therapy offers new standard treatment option for soft tissue sarcoma
Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. view more (2009-09-22)
Genomic profiling of lung tumors helps doctors choose most effective treatment
Determining the genetic profile of a particular lung tumor can help clinicians make the crucial decision about which chemotherapy treatment to try first. view more (2007-09-28)
New method proposed for determining which patients should get treatment for colorectal cancer
A new study being presented at the American Society of Clinical Oncology meeting in Chicago (Abstract #4020), may change treatment practice in about 25 percent of patients with colon cancer and is the basis for proposed changes to the way colorectal cancers will be staged. view more (2008-05-19)
Combining therapies can improve survival for early-stage breast cancer patients
Patients with early-stage breast cancer who are treated with both chemotherapy and tamoxifen have a higher survival rate than patients who receive only tamoxifen. view more (2007-04-04)
Triple drug combination is promising option to treat metastatic HER2+ breast cancer
Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options. view more (2009-05-15)
Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy
Though the growing shift toward oral chemotherapy agents offers cancer patients greater freedom and independence during their treatment, physicians say use of the new medications also poses more chances for patients to skip doses, miss prescription refills, and take their drugs in a dangerous way. view more (2009-05-29)
Longer anthracycline therapy reduces heart failure in adult cancer patients
Stretching out a dose of chemotherapy over six or more hours may reduce the risk of heart problems caused by certain commonly used cancer drugs. view more (2006-11-27)
Racial disparities persist in the treatment of lung cancer
Black patients suffering from lung cancer are less likely to receive recommended chemotherapy and surgery than white lung cancer patients, a disparity that shows no signs of lessening. view more (2009-04-13)
Study shows drug combination improves outcome for advanced non-small cell lung cancer
A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC). view more (2009-06-01)
Personalized diets may offer relief to advanced cancer patients
It is well known that cancer patients undergoing chemotherapy and radiation therapy often experience nausea and loss of appetite. But until now, few researchers have looked into why this happens and what can be done to ensure that cancer patients maintain a healthy diet during treatment. view more (2007-03-12)
New treatment more than doubles survival for high risk childhood leukemia
Results of a phase two clinical trial published October 5th in the Journal of Clinical Oncology show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome-positive acute... view more... (2009-10-07)
Confusing risk information may lead to poor cancer treatment choices
A new study from researchers at the University of Michigan Comprehensive Cancer Center found that a tool commonly used by doctors to estimate the risk of a woman's breast cancer returning after surgery is not very effective at explaining risk to patients. view more (2008-12-09)
OHSU Cancer Institute research gives hope for chemo holidays for men with advanced prostate cancer
Oregon Health & Science University Cancer Institute researchers, in a first-of-its-kind study, have found that even men with advanced prostate cancer can take a much-needed safe break, or holiday, from chemotherapy. view more (2008-02-26)
|
|
| Page
8 of
55 |
1084 Results |
|
|
|
Sort By:
Page Views | Date |
|
